CAS OpenIR  > 干细胞与生殖生物学国家重点实验室
Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors
Source PublicationJOURNAL OF CLINICAL ONCOLOGY
2020
Volume38Issue:15
Wang Zhenguang; Chen Meixia; Zhang Yan; Liu Yang; Yang Qingming; Nie Jing; Shen Lianjun; Jiang Pengfei; He Jiaping; Ye Xun; Cao Wei; Wang HY(王皓毅); Han Weidong
Document Type期刊论文
Identifierhttp://ir.ioz.ac.cn/handle/000000/14558
Collection干细胞与生殖生物学国家重点实验室
Recommended Citation
GB/T 7714
Wang Zhenguang,Chen Meixia,Zhang Yan,et al. Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors[J]. JOURNAL OF CLINICAL ONCOLOGY,2020,38(15).
APA Wang Zhenguang.,Chen Meixia.,Zhang Yan.,Liu Yang.,Yang Qingming.,...&Han Weidong.(2020).Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors.JOURNAL OF CLINICAL ONCOLOGY,38(15).
MLA Wang Zhenguang,et al."Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors".JOURNAL OF CLINICAL ONCOLOGY 38.15(2020).
Files in This Item: Download All
File Name/Size DocType Version Access License
Phase I study of CRI(454KB)期刊论文出版稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wang Zhenguang]'s Articles
[Chen Meixia]'s Articles
[Zhang Yan]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wang Zhenguang]'s Articles
[Chen Meixia]'s Articles
[Zhang Yan]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang Zhenguang]'s Articles
[Chen Meixia]'s Articles
[Zhang Yan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Phase I study of CRISPR-engineered CAR-T.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.